Questions about Migraine
What are the real-world results of using eptinezumab for ongoing episodic or chronic migraine attacks?
Real-world data from the BE-FREE study shows that eptinezumab reduces pain intensity and associated symptoms like light sensitivity within 10 to 20 minutes of infusion for patients with ongoing migraine attacks.
Full answer →Does eptinezumab plus education reduce migraine days in chronic migraine patients who overuse medication?
Yes, a 12-week trial found that eptinezumab combined with a brief educational intervention reduced monthly migraine days in adults with chronic migraine and medication overuse.
Full answer →How does resting-state fMRI show brain entropy differences in chronic migraine compared to healthy controls?
Resting-state fMRI shows that people with chronic migraine have lower brain entropy in key brain networks compared to healthy people, and this difference is even greater in chronic migraine than in episodic migraine.
Full answer →Does intravenous eptinezumab help reduce pain and symptoms during an ongoing chronic migraine attack?
Yes, intravenous eptinezumab can reduce pain and symptoms during an ongoing chronic migraine attack, with effects seen within 10-30 minutes of infusion.
Full answer →Does resting-state fMRI show different brain activity in people with chronic migraine?
Yes, resting-state fMRI shows reduced brain entropy and altered low-frequency brain activity in people with chronic migraine compared to healthy controls.
Full answer →Can a smartphone app accurately predict when my migraine attacks will happen?
Smartphone apps can provide short-term predictions for migraine attacks, but current models only predict about a 59% chance of an attack occurring within 24 hours, which is only slightly better than random guessing.
Full answer →